Generic Kaftrio 75mg/50mg/100mg tablets
NHS hospitals in England used £465,897,918 of indicative cost of Generic Kaftrio 75mg/50mg/100mg tablets in the 12 months to July 2026, about 1.8% of all hospital medicines spend. That is down 20.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Generic Kaftrio 75mg/50mg/100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Generic Kaftrio 75mg/50mg/100mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Guy's & St Thomas' Nhs Foundation Trust | £53,796,077 |
| Manchester University Nhs Ft | £47,863,944 |
| Royal Papworth Hospital Nhs Ft | £32,141,601 |
| Leeds Teaching Hpls Nhs Trust | £31,478,070 |
| Liverpool Heart & Chest Hosp Found Trust | £27,467,673 |
| University Hospital Southampton Nhs Ft | £23,686,799 |
| Nottingham University Hospitals Trust | £22,408,623 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £21,274,719 |
| Univ Hpls Bristol Nhs Foundation Trust | £20,974,252 |
| King's College Hpl Nhs Foundation Trust | £19,638,844 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.